-
Back in the saddle again, 2022 PMC raises record $69 million—that’s $900 million since 1980!
The world can always use more good news, so here is something great—the Pan-Mass Challenge (PMC), the annual bike-a-thon that raises more money for charity than any other single athletic fundraising event in the country, had its best year yet, raising a record $69 million for Dana-Farber in 2022.
-
Richard and Susan Smith Family receives Institute’s highest honor, the Sidney Farber Medical Research Award
On a beautiful evening in mid-September, members of the Dana-Farber community gathered to celebrate the presentation of the 2022 Sidney Farber Medical Research Award to the Richard and Susan Smith Family.
-
Leadership gift establishes Poorvu Jaffe Chair in Psychosocial Oncology and Palliative Care and launches health equity initiative
Dana-Farber is committed to providing the best possible care to patients from all walks of life. In recent years, the Institute has prioritized expanding its clinical facilities into surrounding communities to better reach medically underserved patients with the Institute’s signature Total Patient Care model, which includes supportive services from the Department of Psychosocial Oncology and…
-
Massachusetts Life Sciences Center grants $2.8 million to establish new center and accelerate drug development
The Massachusetts Life Sciences Center (MLSC) has awarded Dana-Farber $2,811,397 to establish a Center for Emergent Drug Targets (CEDT), which will provide a collaborative environment to streamline and accelerate the earliest stages of drug discovery.
-
Simons Foundation grant targets cell biology
Scientists are often able to pinpoint genomic variants in people with disease, but it is very difficult to understand which of those mutations caused their illness, and even harder to know how that knowledge should inform treatment.
-
Couple commits $2 million to fund groundbreaking clinical trials
In 2017, a mammogram revealed that Langley Perer had ductal carcinoma in situ (DCIS), the very earliest, and highly treatable, stage of breast cancer.
-
Dana-Farber Marathon Challenge raises nearly $7 million in support of Claudia Adams Barr Program investigators
The Dana-Farber Marathon Challenge (DFMC) attracts runners from across the globe as they take on 26.2 miles in support of innovative basic research at Dana-Farber Cancer Institute each year.
-
Back on course with the Boston Marathon® Jimmy Fund Walk
For 34 years, Dana-Farber Cancer Institute supporters have come together for a day of inspiration and hope at the Boston Marathon® Jimmy Fund Walk presented by Hyundai, raising lifesaving funds to defy cancer for patients everywhere.
-
Rasmussen Family funds research into underlying causes of colorectal cancer
Anna and Neil Rasmussen are no strangers to medical research in the quest to find answers to chronic illness—one of their children had been living with ulcerative colitis since she was seven years old.
-
IMS grants drive innovative multiple myeloma research
The International Myeloma Society (IMS) recently awarded three Dana-Farber scientists grants totaling $525,000 to promote research on the blood cancer multiple myeloma.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.